Why Legacy Pathology Archives Matter for Rare-Disease Research
ACCESSWIRE•19/10/2026•08:45 ET
0
Key Highlights
- ➤ScanVan digitizes more than 16,000 slides weekly
- ➤Platform supports collections ranging from thousands to millions of slides
- ➤Leidos developed ScanVan with University of Pittsburgh’s Computational Pathology and AI Center
- ➤Digitized archives enable searchable rare-disease research without physically moving slides
NORTHAMPTON, MA / ACCESS Newswire / October 19, 2026 / Leidos
Why it matters * Rare-disease research needs larger, richer historical datasets * Digitized archives make decades of evidence searchable * Historical tissue can reveal patterns previously missed Pathology archives often contain decades of clinically valuable information that is difficult to access in its original format. Glass slides may reveal evidence of disease patterns and support diagnostic decisions and tissue characteristics that were essential at the time of creation, but as scientific research data they are difficult to search, share and study at scale.
Get started
Create a free account to read the full story.